The Burden of Living With Cutaneous Lupus Erythematosus
- PMID: 36017007
- PMCID: PMC9395260
- DOI: 10.3389/fmed.2022.897987
The Burden of Living With Cutaneous Lupus Erythematosus
Abstract
Cutaneous lupus erythematosus (CLE) is a group of heterogeneous autoimmune disorders primarily affecting the skin. Patients with these conditions are mostly young women when they become sick and often suffer from recurrent skin symptoms or longstanding changes in their physical appearance. CLE disorders lead to different levels of morbidity and can impact profoundly patients' quality of life, particularly in the psychological and social health domains. This review provides a summary of recent research investigating the psychosocial burden of living with CLE and the intersect amongst the disease characteristics, patient factors, and social determinants of health. Furthermore, this review provides insight into patient care and research needs that remain unmet to improve the quality of life of patients living with CLE.
Keywords: cutaneous lupus erythematosus (CLE); disease burden; psychosocial impact; quality of life; racial minorities.
Copyright © 2022 Drenkard, Barbour, Greenlund and Lim.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Understanding the disease burden and unmet needs among patients with cutaneous lupus erythematosus: A qualitative study.Int J Womens Dermatol. 2018 Apr 13;4(3):152-158. doi: 10.1016/j.ijwd.2018.01.002. eCollection 2018 Sep. Int J Womens Dermatol. 2018. PMID: 30175217 Free PMC article.
-
Exploring the Perspectives of Patients Living With Lupus: Retrospective Social Listening Study.JMIR Form Res. 2024 Feb 2;8:e52768. doi: 10.2196/52768. JMIR Form Res. 2024. PMID: 38306157 Free PMC article.
-
Cutaneous lupus erythematosus: An update.Indian Dermatol Online J. 2014 Jan;5(1):7-13. doi: 10.4103/2229-5178.126020. Indian Dermatol Online J. 2014. PMID: 24616847 Free PMC article. Review.
-
A multicentre, cross-sectional study on quality of life in patients with cutaneous lupus erythematosus.Br J Dermatol. 2013 Jan;168(1):145-53. doi: 10.1111/j.1365-2133.2012.11106.x. Epub 2012 Sep 13. Br J Dermatol. 2013. PMID: 22708924 Free PMC article.
-
Influence of Socio-Demographic Factors in Patients With Cutaneous Lupus Erythematosus.Front Med (Lausanne). 2022 Jul 11;9:916134. doi: 10.3389/fmed.2022.916134. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35899206 Free PMC article. Review.
Cited by
-
Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Afimetoran, a Toll-Like Receptor 7 and 8 Inhibitor, in Patients With Cutaneous Lupus Erythematosus: A Phase 1b Randomized, Double-Blind, Placebo-Controlled Study.ACR Open Rheumatol. 2025 Jul;7(7):e70059. doi: 10.1002/acr2.70059. ACR Open Rheumatol. 2025. PMID: 40568766 Free PMC article.
-
Demographic and regional disparities in U.S. adult mortality due to cutaneous lupus erythematosus: insights from a CDC wonder analysis (1999-2020).Arch Dermatol Res. 2025 Feb 18;317(1):435. doi: 10.1007/s00403-025-03926-4. Arch Dermatol Res. 2025. PMID: 39966123 No abstract available.
References
Publication types
LinkOut - more resources
Full Text Sources